soul trial oral semaglutide cardiovascular outcomes 2025 results 2024 Effect of Oral Semaglutide on Cardiovascular Outcomes in Type 2 Diabetes by Extent of Vascular Disease SOUL (Semaglutide cardiOvascular oUtcomes triaL)

Recent studies have shown that Ozempic is effective not only for those with diabetes but also for individuals without diabetes who struggle with obesity or weight-related health concerns

The case reports of DVT in GLP-1 users all described successful treatment with anticoagulants

It has been shown in clinical trials to help individuals lose up to 21% of their initial body weight when combined with a reduced-calorie diet and increased physical activity, when compared to participants who took a placebo Mounjaro (tirzepatide) has numerous advantages, including weight loss and improved control of diabetes symptoms

Theyre relying on the DTC ads they put out in our culture of anti-Fatness to convince you to pump their drugs into your body and inject your hard earned money into their wallets

One user specifically noted losing 23 pounds and said "the constant battle with food is finally over." These results align with what clinical data shows for semaglutide appetite suppression , suggesting the compounded medications are working for at least some percentage of users

If youre interested in going on Ozempic, have a conversation with your prescribing doctor about what you expect from the medication and how it may fit into your lifestyle